Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Tercica, Inc. (Nasdaq: TRCA) today announced financial results for the quarter ended June 30, 2008. Net product sales totaled $6.2 million, compared to $2.0 million in the...
Tercica, Inc. (NASDAQ: TRCA) today announced the first results from the Increlex? Growth Forum Database (IGFD) Registry in two posters presented at the 90th annual meeting of...
Tercica, Inc. (NASDAQ: TRCA) today announced that company management will present at the FBR Capital Markets 12th Annual Spring Investor Conference on Wednesday, May 28, 2008 at...
Tercica, Inc. (Nasdaq:TRCA) today announced financial results for the quarter ended March 31, 2008. Total net product sales totaled $4.3 million, compared to $1.1 million in the...
Tercica, Inc. (NASDAQ: TRCA) today announced the Company will release its 2008 first quarter financial results after market close on Monday, May 12, 2008. Management will...
Tercica, Inc. (Nasdaq: TRCA) today announced that company management will make the following investment community presentations: Cowen & Company 28th Annual Health Care...
Tercica, Inc. (NASDAQ:TRCA) today announced that it has named Richard King as President and Chief Operating Officer. Previously, Mr. King was Tercica?s Chief Operating Officer...
Tercica, Inc. (Nasdaq: TRCA) today announced financial results for the quarter and year ended December 31, 2007. Net product sales for the quarter ended December 31, 2007...
Tercica, Inc. (NASDAQ:TRCA) today announced the Company will release its 2007 fourth quarter and year-end financial results before market open on Wednesday, February 27, 2008...
Tercica, Inc. (NASDAQ: TRCA) today announced that the Company has begun dosing the first patient in a Phase II clinical study evaluating the combination of Genentech, Inc.?s...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
